Results of a phase IIb study in recurrent or refractory glioblastoma patients with the TGF-beta-2 inhibitor AP 12009
暂无分享，去创建一个
U. Bogdahn | K. Schlingensiepen | A. Mahapatra | P. Hau | V. Parfenov | P. Jachimczak | S. Ludwig | H. Heinrichs | V. Olyushin | K. Venkataramana